Solid Biosciences Inc.
Organization details
- Legal name
- Solid Biosciences Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Charlestown
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SLDB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001707502
- EIN
- 90-0943402
Board of directors
-
Adam Koppel · DirectorSince 2023
-
Adam Leo Stone · DirectorSince 2023
-
Alexander Cumbo · Director · President and CEOSince 2023
-
Clare Kahn · DirectorSince 2023
-
Georgia Keresty · DirectorSince 2023
-
Ian F. Smith · DirectorSince 2023
-
Ilan Ganot · DirectorSince 2023
- Since 2023
-
Lynne Marie Sullivan · DirectorSince 2023
-
Martin I. Freed · DirectorSince 2023
- Since 2023
- Since 2023
-
Sukumar Nagendran · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.8%
-
92.8%
-
92.8%
Board connections
11 of this board's directors also sit on 38 other boards. 36 are in the same sector.
-
Freenome Inc. Same sectorvia Adam Leo Stone, Joseph Edelman, Peter Kolchinsky and Rajeev M. Shah
-
Climb Bio Inc. Same sectorvia Alexander Cumbo, Peter Kolchinsky and Rajeev M. Shah
-
Stoke Therapeutics Inc. Same sectorvia Alexander Cumbo, Clare Kahn and Ian F. Smith
-
Vor Biopharma Inc. Same sectorvia Alexander Cumbo, Peter Kolchinsky and Rajeev M. Shah
-
ARS Pharmaceuticals Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Acrivon Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Acumen Pharmaceuticals Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Artiva Biotherapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Bambusa Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Bicara Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Black Diamond Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Evommune Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Foghorn Therapeutics Inc. Same sectorvia Adam Koppel and Ian F. Smith
-
Hemab Therapeutics Holdings Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Immatics N.V. Same sectorvia Adam Leo Stone and Joseph Edelman
-
Jade Biosciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Janux Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
LENZ Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Mineralys Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Nkarta Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Parabilis Medicines Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
PepGen Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Septerna Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Sionna Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
SpyGlass Pharma Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Tyra Biosciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Wave Life Sciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Werewolf Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Adagio Medical Holdings Inc Same sectorvia Joseph Edelman
-
Intellia Therapeutics Inc. Same sectorvia Georgia Keresty
-
Kailera Therapeutics Inc. Same sectorvia Adam Koppel
-
Kardigan Inc. Same sectorvia Joseph Edelman
-
LeonaBio Inc. Same sectorvia Joseph Edelman
-
MeiraGTx Holdings plc Same sectorvia Joseph Edelman
- via Joseph Edelman
-
Odyssey Therapeutics Inc. Same sectorvia Ian F. Smith
-
Taysha Gene Therapies Inc. Same sectorvia Sukumar Nagendran
- via Lynne Marie Sullivan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,675,750
- 28 sales by 7 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 19, 2026 | Brooks Gabriel Officer (Chief Medical Officer) | Open-market sale | −4,374 | $5.62 | $24,582 |
| Oct 18, 2026 | Brooks Gabriel Officer (Chief Medical Officer) | Option exercise | +9,750 | — | — |
| Oct 2, 2026 | Ian F. Smith Director | Option exercise | +3,440 | — | — |
| Jul 2, 2026 | Ian F. Smith Director | Option exercise | +3,440 | — | — |
| Apr 2, 2026 | Ian F. Smith Director | Option exercise | +3,441 | — | — |
| Feb 18, 2026 | Alexander Cumbo Director, Officer (President and CEO) | Open-market sale | −16,644 | $5.82 | $96,868 |
| Feb 18, 2026 | Hanrahan Jessie Officer (Chief Regulatory Officer) | Open-market sale | −4,134 | $5.82 | $24,060 |
| Feb 18, 2026 | Ilan Ganot Director | Open-market sale | −2,658 | $5.82 | $15,470 |
| Feb 18, 2026 | Herzich Paul Officer (Chief Technology Officer) | Open-market sale | −3,616 | $5.82 | $21,045 |
| Feb 18, 2026 | Howton David T Officer (Chief Operating Officer) | Open-market sale | −7,469 | $5.82 | $43,470 |
| Feb 18, 2026 | Brooks Gabriel Officer (Chief Medical Officer) | Open-market sale | −0 | $5.82 | $0 |
| Feb 18, 2026 | Tan Kevin Officer (CFO & Treasurer) | Open-market sale | −5,404 | $5.82 | $31,451 |
| Feb 13, 2026 | Alexander Cumbo Director, Officer (President and CEO) | Option exercise | +30,031 | — | — |
| Feb 13, 2026 | Hanrahan Jessie Officer (Chief Regulatory Officer) | Option exercise | +8,125 | — | — |
| Feb 13, 2026 | Ilan Ganot Director | Option exercise | +4,861 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Solid Biosciences Inc.
Who is the CEO of Solid Biosciences Inc.?
Alexander Cumbo is Solid Biosciences Inc.'s President and CEO.
How many directors are on Solid Biosciences Inc.'s board?
Solid Biosciences Inc.'s board has 13 directors: Adam Koppel, Adam Leo Stone, Alexander Cumbo, Clare Kahn, Georgia Keresty, Ian F. Smith, Ilan Ganot, Joseph Edelman, Lynne Marie Sullivan, Martin I. Freed and 3 others.
Are Solid Biosciences Inc. insiders buying or selling shares?
Over the last 12 months, Solid Biosciences Inc. insiders made no open-market purchases and sold $2.7 million of shares in 28 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="solid-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.